Janux Therapeutics, Inc. (JANX)

13.65 +0.28 (+2.09%) USD  |  NASDAQ  |  Feb 24, 16:00
13.48 -0.17 (-1.25%) After-Hours: 20:00
More

Janux Therapeutics Research and Development Expense (Quarterly) : 34.63M for Sept. 30, 2025

Research and Development Expense (Quarterly) Chart

View Research and Development Expense (Quarterly) for JANX.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Research and Development Expense (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

R&D Expense Definition

View R&D Expense Definition
Start Trial

R&D expense is a line item from many companies' income statements.

Read full definition.

Research and Development Expense (Quarterly) Range, Past 5 Years

View Research and Development Expense (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Research and Development Expense (Quarterly) Benchmarks

View Research and Development Expense (Quarterly) Benchmarks
Start Trial
Bristol Myers Squibb Co. 2.561B
Eli Lilly & Co. 3.802B
Ionis Pharmaceuticals, Inc. 217.13M
MannKind Corp. 14.06M
EyePoint Plc 47.75M